Αρχειοθήκη ιστολογίου

Παρασκευή 23 Φεβρουαρίου 2018

SOX2OT variant 7 contributes to the synergistic interaction between EGCG and Doxorubicin to kill osteosarcoma via autophagy and stemness inhibition

Doxorubicin is the preferred chemotherapeuticdrug for osteosarcoma treatment of which clinical efficacy is limited because of its chemo-resistance and cardiac toxicity. It is necessary to develop the combinati...

from #ORL-AlexandrosSfakianakis via ola Kala on Inoreader http://ift.tt/2Frebsj

Δεν υπάρχουν σχόλια:

Δημοσίευση σχολίου